VIVS
VIVS
NASDAQ · Biotechnology

Vivosim Labs Inc

$1.62
-0.07 (-4.14%)
As of Mar 29, 11:01 PM ET ·
Financial Highlights (FY 2026)
Revenue
270.2K
Net Income
-4,668,325
Gross Margin
96.5%
Profit Margin
-1,727.8%
Rev Growth
-54.2%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 96.5% 96.5% 53.9% 53.9%
Operating Margin -8,761.1% -7,885.0% 10.2% 11.9%
Profit Margin -1,727.8% -1,641.4% 12.7% 9.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 270.2K 590.1K 3.56M 2.77M
Gross Profit 260.9K 569.7K 1.92M 1.49M
Operating Income -23,675,059 -46,533,201 363.1K 329.5K
Net Income -4,668,325 -9,175,567 452.9K 261.8K
Gross Margin 96.5% 96.5% 53.9% 53.9%
Operating Margin -8,761.1% -7,885.0% 10.2% 11.9%
Profit Margin -1,727.8% -1,641.4% 12.7% 9.5%
Rev Growth -54.2% -54.2% +0.2% +7.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 2.21M 2.49M
Total Equity 4.37M 4.42M
D/E Ratio 0.51 0.56
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -4,409,355 -9,148,039 509.0K 375.7K
Free Cash Flow 445.4K 284.4K